Exane Derivatives’s A.O. Smith AOS Stock Holding History

Exane Derivatives’s Portfolio AOS Stock Details AOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,728	Closed	-$621K	–	787
2022 Q1	$621K	Buy	9,728 +1,775	+22%	+$129K	0.18%	156
2021 Q4	$683K	Buy	7,953 +2,109	+36%	+$161K	0.17%	138
2021 Q3	$357K	Buy	5,844 +840	+17%	+$58.7K	0.09%	249
2021 Q2	$355K	Sell	5,004 -3,610	-42%	-$249K	0.08%	246
2021 Q1	$582K	Sell	8,614 -279	-3%	-$17K	0.17%	131
2020 Q4	$487K	Buy	+8,893	New	+$490K	0.14%	163
2017 Q4	–	Sell	-1	Closed	-$59	–	609
2017 Q3	$59	Sell	1 -4	-80%	-$224	﹤0.01%	530
2017 Q2	$282	Hold	5	–	–	﹤0.01%	524
2017 Q1	$256	Hold	5	–	–	﹤0.01%	457
2016 Q4	$237	Buy	+5	New	+$241	﹤0.01%	506
2016 Q3	–	Sell	-2	Closed	-$88	–	629
2016 Q2	$88	Hold	2	–	–	﹤0.01%	473
2016 Q1	$76	Sell	2 -12	-86%	-$420	﹤0.01%	541
2015 Q4	$536	Hold	14	–	–	﹤0.01%	418
2015 Q3	$456	Hold	14	–	–	﹤0.01%	451
2015 Q2	$504	Hold	14	–	–	﹤0.01%	460
2015 Q1	$460	Sell	14 -10	-42%	-$304	﹤0.01%	465
2014 Q4	$677	Buy	+24	New	+$627	﹤0.01%	484

Other funds holding AOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Exane Derivatives's AOS Position: Q2 2022 in Review

Exane Derivatives sold out of A.O. Smith (AOS) in Q2 2022, closing a stake of 9,728 shares — an estimated $621K sold.

Exane Derivatives first reported a position in AOS in Q4 2014 and held it in 17 quarters. The position peaked at $683K in Q4 2021. 545 funds tracked by Wall St. Rank hold AOS as of Q2 2022.

Exane Derivatives reported no remaining A.O. Smith position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 9,728 A.O. Smith shares in Q2 2022, an estimated $621K.
Exane Derivatives first reported a position in A.O. Smith in Q4 2014 and held it in 17 quarters.
Exane Derivatives's A.O. Smith position peaked at $683K in Q4 2021.
545 funds tracked by Wall St. Rank held A.O. Smith as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.